Insider · CIK 0001923461
Astrid Borkowski
Files at HLVX (HilleVax, Inc.). First filing Nov 13, 2023, latest Feb 12, 2024.
In brief
Astrid Borkowski files SEC Form 4 as officer at HLVX (HilleVax, Inc.). Since Nov 13, 2023, Astrid Borkowski has reported 0 open-market buys worth $0 and 5 open-market sells worth $706k, the latest filed on Feb 12, 2024.
A track record needs three past buys with six months of prices behind them; Astrid Borkowski has 0, so none is measured yet.
The newest scored trade: sold $59k of HLVX on Feb 8, 2024, filed Feb 12, 2024, scored 37 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | HilleVax, Inc. | $59k 3,933 shares | -2% | - | |
| 26Weak | HLVXsell HilleVax, Inc. | $155k 10,000 shares | -6% | - | |
| 34Weak | HLVXsell HilleVax, Inc. | $287k 20,000 shares | -10% | - | |
| 26Weak | HLVXsell HilleVax, Inc. | $140k 10,000 shares | -5% | - | |
| 23Weak | HLVXsell HilleVax, Inc. | $65k 5,000 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 18, 2023 | HLVX HilleVax, Inc. | 10,000 0.02% of outstanding | $155k | Dec 15, 2023 | none |
| Dec 5, 2023 | HLVX HilleVax, Inc. | 10,000 0.02% of outstanding | $142k | Dec 1, 2023 | none |
| Dec 5, 2023 | HLVX HilleVax, Inc. | 10,000 0.02% of outstanding | $145k | Dec 4, 2023 | none |
| Nov 27, 2023 | HLVX HilleVax, Inc. | 5,000 0.01% of outstanding | $65k | Nov 8, 2023 | none |
| Nov 27, 2023 | HLVX HilleVax, Inc. | 10,000 0.02% of outstanding | $140k | Nov 17, 2023 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock | -3,933 | $14.93 | $59k | 161,260 | Feb 12, 2024 |
| Feb 8, 2024 | HLVX HilleVax, Inc. | AGrant or award Common Stock | +53,632 | $0.00 | $0 | 214,892 | Feb 12, 2024 |
| Feb 8, 2024 | HLVX HilleVax, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +69,852 | $0.00 | $0 | 69,852 | Feb 12, 2024 |
| Dec 15, 2023 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock | -10,000 | $15.50 | $155k | 165,193 | Dec 18, 2023 |
| Dec 1, 2023 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock | -10,000 | $14.20 | $142k | 185,193 | Dec 5, 2023 |
| Dec 4, 2023 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock | -10,000 | $14.50 | $145k | 175,193 | Dec 5, 2023 |
| Nov 17, 2023 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock | -10,000 | $14.00 | $140k | 195,193 | Nov 20, 2023 |
| Nov 8, 2023 | HLVX HilleVax, Inc. | SOpen-market sale Common Stock | -5,000 | $13.00 | $65k | 205,193 | Nov 13, 2023 |
Questions about Astrid Borkowski
Answered from the filings on this page, as of the latest one.
Is Astrid Borkowski buying or selling?
Not in the last 12 months. Astrid Borkowski's latest open-market trade on SEC Form 4 was sold $59k of HLVX on Feb 8, 2024.
How did Astrid Borkowski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Astrid Borkowski has 0.
Where does Astrid Borkowski file Form 4?
Astrid Borkowski has filed Form 4 at HLVX (HilleVax, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.